Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heidi M. Egloff
Observed name:
Heidi Egloff
Institution:
Sparrow Hospital
Observed institutions:
Mayo Clinic,
University of Michigan,
Sparrow Hospital,
Michigan Medicine,
U-M Rogel Cancer Center
OpenAlex ID:
A5044969370
Publication Rates of Abstracts Presented at the Society of General Internal Medicine Annual Meeting
2017
·
Heidi M. Egloff
, Colin P. West
, et al.
·
Journal of General Internal Medicine
·
26
PDF
Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening
2021
·
Sarah E. H. Moorman
, Akshat C. Pujara
, et al.
·
American Journal of Roentgenology
·
25
Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review
2018
·
Heidi Egloff
, Kelley M. Kidwell
, et al.
·
Case Reports in Oncology
·
15
Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity?
2016
·
Heidi Egloff
, Aminah Jatoi
·
Cancer Investigation
·
6
Pemetrexed for Ovarian Cancer: A Systematic Review of the Published Literature and a Consecutive Series of Patients Treated in a Nonclinical Trial Setting
2014
·
Heidi Egloff
, Aminah Jatoi
·
Case Reports in Oncology
·
4
Peer Review of Abstracts Submitted to An Internal Medicine National Meeting: Is It a Predictor of Future Publication?
2018
·
Cecilia Scholcoff
, Payal Sanghani
, et al.
·
Journal of General Internal Medicine
·
3
PDF
Phase 1 dose-escalation trial of talazoparib in combination with belinostat in select advanced solid tumors.
2025
·
Monika L. Burness
, Ulka N. Vaishampayan
, et al.
·
Journal of Clinical Oncology
·
2
Ado-trastuzumab emtansine (T-DM1) induced pulmonary toxicity: A retrospective analysis of a single institution experience.
2018
·
Heidi Egloff
, Kelley M. Kidwell
, et al.
·
Journal of Clinical Oncology
·
1
Othr-12. Driving Recommendations in Patients With Newly Diagnosed Breast Cancer Brain Metastases
2019
·
Leigh Swartz
, Heidi Egloff
, et al.
·
Neuro-Oncology Advances
Endocrine therapy discontinuation rates in older women with early stage breast cancer who are candidates for omission of radiation.
2019
·
Heidi Egloff
, Leigh Klaus Swartz
, et al.
·
Journal of Clinical Oncology
55-Year-Old Woman With Recurrent Syncope
2016
·
Andrew M. Briggler
, Heidi M. Egloff
, et al.
·
Mayo Clinic Proceedings
Show more works
View as search
Works count:
11
Citation count:
82
H-index:
4
I10-index:
3
Year
Topic
Type